Literature DB >> 26448665

Delayed Administration and Contraindicated Drugs Place Hospitalized Parkinson's Disease Patients at Risk; Doxorubicin Liposomal Mix-up; Avoid Mix-ups Between Hydroxyprogesterone and Medroxyprogesterone.

Michael R Cohen1, Judy L Smetzer2.   

Abstract

These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (www.ismp.org), by calling 800-FAIL-SAFE, or via e-mail at ismpinfo@ismp.org. ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications.

Entities:  

Year:  2015        PMID: 26448665      PMCID: PMC4589854          DOI: 10.1310/hpj5007-559

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  4 in total

1.  Prescribing medications in Parkinson's disease (PD) patients during acute admissions to a District General Hospital.

Authors:  K Nadia Magdalinou; Anne Martin; Belinda Kessel
Journal:  Parkinsonism Relat Disord       Date:  2007-01-22       Impact factor: 4.891

2.  Medication management in people with Parkinson's disease during surgical admissions.

Authors:  C P Derry; K J Shah; L Caie; C E Counsell
Journal:  Postgrad Med J       Date:  2010-06       Impact factor: 2.401

3.  Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease.

Authors:  Jyhgong Gabriel Hou; Laura J Wu; Suzanne Moore; Constance Ward; Michele York; Farah Atassi; Linda Fincher; Naomi Nelson; Aliya Sarwar; Eugene C Lai
Journal:  Parkinsonism Relat Disord       Date:  2012-01-09       Impact factor: 4.891

Review 4.  The parkinsonism-hyperpyrexia syndrome.

Authors:  Edward J Newman; Donald G Grosset; Peter G E Kennedy
Journal:  Neurocrit Care       Date:  2008-08-20       Impact factor: 3.210

  4 in total
  1 in total

1.  Pharmacotherapeutic management of Parkinson's disease inpatients: how about asking hospital pharmacists?

Authors:  Unax Lertxundi Etxebarria; Itziar Palacios-Zabalza; Itziar Ibarrondo; Saioa Domingo-Echaburu; Rafael Hernandez; Arantxa Isla; Marian Solinis
Journal:  Eur J Hosp Pharm       Date:  2020-12-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.